PCRopsis Lysis Beads, IVDD: a) 25 tubes , REF 597000; b) 25 tubes, REF 597825; c) 50 tubes, REF 5...

FDA Device Recall #Z-1298-2023 — Class II — February 21, 2023

Recall Summary

Recall Number Z-1298-2023
Classification Class II — Moderate risk
Date Initiated February 21, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Entopsis , Inc.
Location Medley, FL
Product Type Devices
Quantity 363 units

Product Description

PCRopsis Lysis Beads, IVDD: a) 25 tubes , REF 597000; b) 25 tubes, REF 597825; c) 50 tubes, REF 597850; d) 25 grams, REF 5970025; e) 1000 kilogram, REF 5971000; coated beads that facilitate lysis of microorganisms; nucleic acid extraction from a variety of biological samples

Reason for Recall

Presence of misleading label statements on the product label.

Distribution Pattern

Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

Lot / Code Information

a) REF 597000, Lot Numbers: 2, Exp. 05/2024; 3, Exp. 6024; b) REF 597825, Lot Numbers: 5, Exp. 06/2024; c) REF 597850, Lot Numbers: 2, Exp. 05/2024; d) REF 5970025, Lot Numbers: 2, Exp. 05/2024; 3, Exp. 06/2024; 4, Exp. 06/2024; 5, Exp. 06/2024; e) REF 5971000, Lot Numbers: 4, Exp. 06/2024

Other Recalls from Entopsis , Inc.

Recall # Classification Product Date
Z-1299-2023 Class II PCRopsis Reagent RVD with RVD Enhancer: a) 1 ... Feb 21, 2023
Z-1295-2023 Class II PCRopsis BCSNano (1mL), REF 2276001; nucleic ac... Feb 21, 2023
Z-1301-2023 Class II PCRopsis Support: a) 1 mL, REF 787001; b) 0.2... Feb 21, 2023
Z-1300-2023 Class II PCRopsis Reagent RVD-RT, IVD: a) 1 mL, REF 78... Feb 21, 2023
Z-1297-2023 Class II PCRopsis Activator: a) 1.5mL, REF 228001; b) 0... Feb 21, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.